Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationGranulocytesBone Marrow CellsHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisAntigens, CD34Combined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationBlood Component RemovalStem Cell TransplantationHematopoiesisCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseBusulfanMyeloablative AgonistsHematopoietic Stem CellsBone MarrowTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalEtoposideThiotepaRemission InductionAntineoplastic Agents, AlkylatingRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineStem CellsAmyloidosisCytarabineHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraCord Blood Stem Cell TransplantationTissue DonorsRetrospective StudiesWhole-Body IrradiationNeoplasmsSurvival RateTime FactorsSurvival AnalysisInfectionLymphoma, T-CellHistocompatibilityDoxorubicinPlatelet CountBone Marrow PurgingLeukemia, Myeloid, AcutePOEMS SyndromeHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemiaBlood Cell CountTransplantation, IsogeneicRecombinant ProteinsDexamethasoneBlood CellsVidarabineFollow-Up StudiesLymphomaAntineoplastic AgentsBone Marrow DiseasesProspective StudiesBlood Transfusion, AutologousCytomegalovirus InfectionsFatal OutcomeAnemia, AplasticFeasibility StudiesGraft vs Leukemia EffectBone and BonesImmunophenotypingMyelodysplastic SyndromesT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCell SeparationHematologic DiseasesLeukocytes, MononuclearPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow CytometryLiver TransplantationCells, CulturedPrognosisHLA AntigensBlood DonorsLeukocyte Count